This article was provided by our partner, the American Partnership for Eosinophilic Disorders (APFED). It has been reviewed by Bionews for accuracy and relevance. The views and opinions expressed are those of the author and do not necessarily reflect the views of Bionews or ANCA Vasculitis News. When…
Guest Voices
Rita Martins is a dedicated clinical pharmacist with extensive experience in primary care and hospital settings. Passionate about patient-centered care, she empowers patients and caregivers through education, ensuring they are actively involved in their treatment journey. With a strong commitment to fostering engagement and delivering high-quality care, Rita strives to…
Recent Posts
- Why EGPA should be included in more ANCA vasculitis clinical trials
- Study identifies inflammatory protein as potential treatment target in AAV
- Mirador licenses long-acting antibody therapy for AAV development
- Embracing the power of many in life with ANCA vasculitis
- Kidney biopsy findings linked to recovery after severe AAV kidney injury